The therapeutic potential of cannabinoids for integumentary wound management

The increasing legalization of Cannabis for recreational and medicinal purposes in the United States has spurred renewed interest in the therapeutic potential of cannabinoids (CBs) for human disease. The skin has its own endocannabinoid system (eCS) which is a key regulator of various homeostatic processes, including those necessary for normal physiologic wound healing. Data on the use of CBs for wound healing are scarce. Compelling pre-clinical evidence supporting the therapeutic potential of CBs to improve wound healing by modulating key molecular pathways is herein reviewed. These findings merit further exploration in basic science, translational and clinical studies.

Automated summary

The increasing legalization of Cannabis in the United States has sparked interest in the therapeutic potential of cannabinoids for human diseases. The skin's endocannabinoid system plays a key role in wound healing processes, and there is limited data on the use of cannabinoids for this purpose. Pre-clinical evidence supports the idea that cannabinoids may improve wound healing by modulating key molecular pathways, warranting further exploration in basic science, translational, and clinical studies.